Chronic Condition Management

Study highlights benefits of GPS tracking, geo-fencing and two-way communication.

Study examined Amazon’s RxPass to see how it affected medication adherence and cost

Amid mounting evidence of GLP-1 receptor agonists’ efficacy as weight loss drugs, ACP calls on policymakers to ensure access for patients in need.

Journavx, by Vertex Pharmaceuticals, is a well-tolerated medicine without evidence of addictive potential indicated for use across all types of moderate-to-severe acute pain.

Test is the first measuring lipoprotein (a) in nmol/L and will help assess cardiovascular disease risk in adults

An infectious disease expert describes the state of AMR – and how to fight it.

An infectious disease expert describes the state of AMR – and how to fight it.

An infectious disease expert describes the state of AMR – and how to fight it.

An infectious disease expert describes the state of AMR – and how to fight it.

A study published in The Annals of Family Medicine has highlighted the potential of flexible, practice-centered interventions to advance behavioral health integration in primary care settings.

An infectious disease expert describes the state of AMR – and how to fight it.

An infectious disease expert describes the state of AMR – and how to fight it.

A recent study determined that most primary care physicians felt underprepared and lacked confidence in their ability to provide clinical genetic services to patients.

AI Optics secures FDA Clearance for handheld retinal imaging system, paving the way for improved vision screening

Only 3% and 7% of primary care practices’ EHRs, respectively, were able to report widely recommended quality measures required for alcohol-related prevention and treatment.

Biden administration was criticized for not following through on flavored cigarette rule.

PanopticAI Vital Signs is the first FDA-cleared mobile application for contactless pulse rate measurement using the built-in camera of iPhones and iPads

Proponents say the surgical procedures are underutilized and misunderstood in contemporary medicine.

With high demand but high prices for antiobesity drugs, patients may fall for phony pharmaceuticals.

This year’s scholars will focus their research on “what works” in real-world approaches to Long COVID and Type 2 Diabetes.

GLP-1 drugs have proven effective in weight loss, but factors like insurance, what industry you work in, or gender, can all affect access

How telehealth organizations, med spas and other nontraditional providers can lead the charge on GLP-1 medications.

One in four Americans experience functional decline by age 65, making fall risk management crucial for primary care practices.

A new survey shows 11% of patients do not plan to get vaccinated, 54% are concerned about vaccine access—but 89% trust health care providers for vaccine information.

Surge in GLP-1RA use has researchers looking at all benefits of the drugs, but also the risk to the pancreas and kidneys

Boston Scientific showcases promising data on heart treatments at AF Symposium 2025

Despite the proven effectiveness of cardiac rehabilitation services, high out-of-pocket costs may prevent patients from participating in the programs.

A machine learning tool designed to analyze vocal patterns for signs of depression successfully identified depression in 71% of patients who had it.

New prices would take effect in 2027.

Researchers found that common wearable devices could help patients manage their IBD better